240 related articles for article (PubMed ID: 932190)
1. Immune function of successfully treated lymphoma patients.
King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
[TBL] [Abstract][Full Text] [Related]
2. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
3. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
Moertel CG; Ritts RE; Schutt AJ; Hahn RG
Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
[TBL] [Abstract][Full Text] [Related]
5. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
Shiftan TA; Caviles AP; Mendelsohn J
Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
[TBL] [Abstract][Full Text] [Related]
8. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.
Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL
Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577
[TBL] [Abstract][Full Text] [Related]
9. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
[TBL] [Abstract][Full Text] [Related]
11. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
12. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte populations and cellular immune reactions in juvenile rheumatoid arthritis.
Hoyeraal HM; Froland SS; Wisloff F
Scand J Immunol; 1975; 4(8):801-10. PubMed ID: 1082632
[TBL] [Abstract][Full Text] [Related]
14. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
15. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
Roth JA; Grimm EA; Morton DL
Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
17. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
Churchill WH; Rocklin RR; Moloney WC; David JR
Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
[No Abstract] [Full Text] [Related]
18. Monocyte function in Hodgkin's disease.
Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
[TBL] [Abstract][Full Text] [Related]
19. SPLEEN/PATHOL.
Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
Simmler MC; Rameau G; Chou MJ; Mathé G
Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
